Medicare Low Income Subsidy Equality Act of 2026
- Sponsor
- Rescom. Hernández, Pablo Jose [D-PR-At Large]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Oct 22, 2026
Bottom line
The bill seeks to eliminate a long-standing disparity in federal healthcare subsidies, providing low-income Medicare Part D beneficiaries in U.S. territories with the same financial assistance for prescription drugs as those in the 50 States.
What it actually does
This bill, the "Medicare Low Income Subsidy Equality Act of 2026," amends the Social Security Act to extend premium and cost-sharing subsidies under Medicare Part D to low-income beneficiaries residing in Puerto Rico and other U.S. territories, who are currently excluded from these benefits. It also revises the federal matching formula for Medicaid in these territories to support the increased federal contribution for prescription drug subsidies, aiming to achieve parity with the 50 States and the District of Columbia.
Proponents argue
Proponents argue that the current exclusion of U.S. territories from full Medicare Part D low-income subsidies is discriminatory and creates significant health and economic disparities for vulnerable populations. They contend that extending these subsidies is a matter of equity and will improve access to essential prescription drugs, reduce out-of-pocket costs, and alleviate financial burdens on low-income seniors and individuals with disabilities in these regions.
Opponents contend
While direct opposition to equalizing benefits for low-income seniors is rare, potential opponents might raise concerns about the fiscal implications of expanding federal programs to territories, particularly without corresponding revenue generation from those regions. They might also argue that such expansions could strain federal budgets or that local governments should bear a greater share of healthcare costs for their residents.
The bill is short and relatively straightforward, allowing for a quick and comprehensive understanding of its core provisions.
Section 2(a) of the bill, amending Section 1860D-14(a)(3) of the Social Security Act.
Elimination of Territorial Exclusion for Medicare Part D Low-Income Subsidies (LIS)
This provision removes the existing statutory language that prevents low-income Medicare Part D beneficiaries residing in U.S. territories, including Puerto Rico, from receiving the same premium and cost-sharing subsidies available to those in the 50 States and the District of Columbia. It also clarifies that the poverty line for the 48 contiguous States will apply to individuals in territories for subsidy eligibility, ensuring a uniform standard.
Supporters argue
Supporters argue this provision corrects a long-standing inequity, ensuring that all low-income Medicare beneficiaries, regardless of their place of residence within the U.S. system, receive equal access to vital prescription drug assistance. This will improve health outcomes and financial stability for vulnerable populations.
Critics contend
No specific opposition is typically raised against the principle of equalizing benefits for low-income seniors. However, general fiscal conservatives might express concern about the overall cost increase to the federal budget without specific opposition to the equity aspect.
Tradeoffs
The primary tension is between the principle of equal treatment for all U.S. citizens/residents and the fiscal implications of expanding federal benefits to territories, which historically have different federal funding structures.
Section 2(b) of the bill, amending Section 1935 of the Social Security Act.
Revised Federal Medical Assistance Percentage (FMAP) Computation for Territories to Support LIS
This provision modifies how the federal share of Medicaid costs (Federal Medical Assistance Percentage, or FMAP) is calculated for U.S. territories, specifically for the purpose of supporting the low-income prescription drug subsidies. Starting in January 2027, it establishes a new computation method for territories that aims to increase the federal contribution, moving away from previous capped funding structures towards a more equitable share comparable to the 50 States for these specific drug program costs.
This provision explicitly states that for individuals not residing in the 50 States or D.C., the poverty line used for determining Medicare Part D Low-Income Subsidy (LIS) eligibility shall be the poverty line for the 48 contiguous States and the District of Columbia.
Section 2(a)(3), amending Section 1860D-14(a)(3)(C) of the Social Security Act.
Why it matters:This is standard legislative practice for technical clarifications to ensure consistent application of federal standards across different jurisdictions.
Case for: Supporters would argue this ensures a uniform standard for LIS eligibility, preventing territories from potentially using different, possibly lower, poverty thresholds that could disadvantage their residents. It ensures true parity in eligibility.
Case against: No direct case against, as it clarifies an equity measure. However, some might argue that a territory-specific poverty line, accounting for local cost of living differences, might be more appropriate in some contexts, though for LIS parity, a federal standard is desired.
Estimated impact: Ensures that all low-income individuals in territories meeting the federal poverty threshold for the mainland U.S. are eligible for subsidies, potentially expanding the pool of eligible beneficiaries.